Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/19/2019 08/20/2019 08/21/2019 08/22/2019 08/23/2019 Date
159.25(c) 159.11(c) 161.25(c) 160.93(c) 158.96(c) Last
1 903 125 2 807 229 3 123 136 1 488 460 3 123 844 Volume
+0.63% -0.09% +1.34% -0.20% -1.22% Change
More quotes
Financials (USD)
Sales 2019 15 515 M
EBIT 2019 7 119 M
Net income 2019 -3 019 M
Debt 2019 19 800 M
Yield 2019 1,86%
Sales 2020 15 658 M
EBIT 2020 7 214 M
Net income 2020 835 M
Debt 2020 15 926 M
Yield 2020 1,92%
P/E ratio 2019 -20,8x
P/E ratio 2020 64,7x
EV / Sales2019 4,64x
EV / Sales2020 4,35x
Capitalization 52 144 M
More Financials
Company
Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments:... 
Sector
Pharmaceuticals
Calendar
09/08Presentation
More about the company
Surperformance© ratings of Allergan plc
Trading Rating : Investor Rating :
More Ratings
Latest news on ALLERGAN PLC
08/23Pending mergers and acquisitions involving U.S. firms that need Chinese appro..
RE
08/23ALLERGAN : Form 8.3 -
DJ
08/23AMGEN : and Allergan Announce Positive Top-Line Results from Comparative Clinica..
AQ
08/22ALLERGAN : Form 8.3 -
DJ
08/21ABBVIE : Form 8.3 -
DJ
08/20ALLERGAN : Form 8.3 -
DJ
08/20DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan plc
AQ
08/20NEWS HIGHLIGHTS : Top Company News of the Day
DJ
08/20NEWS HIGHLIGHTS : Top Company News of the Day
DJ
08/20NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
Analyst Recommendations on ALLERGAN PLC
More recommendations
Sector news : Pharmaceuticals - NEC
08/23NOVARTIS : Delay on Data Manipulation Probed
DJ
08/23GLAXOSMITHKLINE : Achieves Positive Results Blood Cancer Treatment Study
DJ
08/22Alexion Up Nearly 8%, on Pace for Largest Percent Increase Since April 2018 -..
DJ
08/22ABBVIE : Form 8.3 -
DJ
08/22EXPLAINER : What are the obstacles to Bayer settling Roundup lawsuits?
RE
More sector news : Pharmaceuticals - NEC
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 180,62  $
Last Close Price 158,96  $
Spread / Highest target 60,4%
Spread / Average Target 13,6%
Spread / Lowest Target -2,49%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Wayne R. Swanton Executive Vice President-Global Operations
Matthew M. Walsh Chief Financial Officer & Executive Vice President
C. David Nicholson Chief Research & Development Officer
Charles Hugh-Jones Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC18.93%52 144
JOHNSON & JOHNSON-1.02%337 101
ROCHE HOLDING LTD.11.71%237 836
MERCK AND COMPANY11.16%217 478
NOVARTIS18.13%204 739
PFIZER-19.63%189 936